U.S. testing of coronavirus vaccine, therapeutic begin

NIH is kicking off the first U.S. clinical trials for COVID-19 with an adaptive trial of remdesivir, an antiviral therapeutic, and a Phase I trial of Moderna’s vaccine candidate. Separately Tuesday, FDA Commissioner Stephen Hahn took to Twitter to debunk media reports referencing a list of 150 drugs at risk for shortages due to the COVID-19 outbreak and CDC warned that it was preparing for a potential pandemic.

The Trump administration has asked Congress for $1.8 billion in additional funding to address the outbreak (see “White House Requests $2.5B”)...